跳至主要内容
临床试验/NCT05737810
NCT05737810已完成不适用

Attitudes and Unmet Needs Among Type 2 Diabetes Patients

Novo Nordisk A/S1 个研究点 分布在 1 个国家目标入组 700 人开始时间: 2023年3月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
700
试验地点
1
主要终点
Current medication burden

研究概览

简要总结

The main purpose of this study is to explore experiences and understand the unmet needs of people with Type 2 Diabetes (T2D) among those who are being managed with basal insulin and those who are insulin naïve in order to understand perspectives for a once weekly insulin option; including any potential barriers to being managed with insulin therapy overall. Study participants will be recruited to complete a 15-minute self-administered online survey.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, age above or equal between 18 to 65 years at the time of signing informed consent.
  • Diagnosed with T2D and currently treating T2D with at least one medication
  • Insulin user that is not using insulin pump
  • Lives in a target country

排除标准

  • Previous participation in this study. Participation is defined as having given informed consent in this study
  • Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
  • Does not meet inclusion criteria requirements

结局指标

主要结局

Current medication burden

时间窗: At the time of survey response (Day1)

Numerical; Multiple select from defined list

Injection perceptions

时间窗: At the time of survey response (Day1)

Likert scale for measurement of agreement from 1 "strongly disagree" to 7 "strongly agree"

Attitudes regarding T2D treatment

时间窗: At the time of survey response (Day1)

Likert scales for measurement of satisfaction from 1 "extremely unsatisfied" to 7 "extremely satisfied" and agreement from 1 "strongly disagree" to 7 "strongly agree"

Attitudes regarding T2D overall

时间窗: At the time of survey response (Day1)

Likert scale for measurement of agreement from 1 "strongly disagree" to 7 "strongly agree"

Attitudes regarding insulin icodec

时间窗: At the time of survey response (Day1)

Likert scales for measurement of likelihood from 0 "not at all likely" to 10" extremely likely" and agreement from 1 "strongly disagree" to 7 "strongly agree; Rank top 3 from defined list

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验